After the intervention, there was a significant difference between the treatment groups in increasing the expression level of BDNF (P=0.031), decreasing craving (P=0.000), and decreasing the symptoms of depression (P=0.018), anxiety (P=0.001), and stress (P=0.012). The gene discussed is BDNF; the disease is depressive symptom measurement.